Cvijic Christine Mikail Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$491,400.00
Insider Sells Quantity
1
Insider Sells Sum
$76,246.94

Insider Activity of Cvijic Christine Mikail

According to the SEC Form 4 filings, Cvijic Christine Mikail, being in a position of

  1. President and CFO at Neurogene Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30603 shares for $900,023,
    over all time since 2024-11-22, has bought 24000 shares for $491,400, and sold 35104 shares for $976,270.

Biography of Cvijic Christine Mikail

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $900,0238100

Comparison of Insiders on Amount of Buys and Sells

2026-07-07SaleNeurogene Inc.
NGNE
President and CFO
4,200
0.0295%
$36.13$151,763-5.86%
2026-07-06SaleNeurogene Inc.
NGNE
President and CFO
600
0.0042%
$36.02$21,613+6.48%
2026-07-02SaleNeurogene Inc.
NGNE
President and CFO
4,061
0.0264%
$34.82$141,417-1.97%
2026-07-01SaleNeurogene Inc.
NGNE
President and CFO
739
0.0047%
$34.06$25,170+2.33%
2026-05-06SaleNeurogene Inc.
NGNE
President and CFO
9,600
0.0594%
$31.25$300,043-2.44%
2026-03-26SaleNeurogene Inc.
NGNE
President and CFO
2,558
0.0167%
$21.62$55,316+40.45%
2026-03-13SaleNeurogene Inc.
NGNE
President and CFO
4,045
0.0253%
$20.81$84,176+35.05%
2026-02-27SaleNeurogene Inc.
NGNE
President and CFO
4,800
0.0331%
$25.11$120,526+21.5%
2025-03-13SaleNeurogene Inc.
NGNE
President and CFO
4,501
0.0216%
$16.94$76,247+16.73%
2024-11-22PurchaseNeurogene Inc.
NGNE
President and CFO
24,000
0.1301%
$20.48$491,400-3.94%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.